10-K/A

FORM 10-K AMENDMENT NO. 1

Company: Xenetic Biosciences, Inc.
Filed: April 30, 2019
Period of Report: December 31, 2018
Accession Number: 0001683168-19-001259

View Document ↗ View on SEC.gov ↗